Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABL Medical is a medical technology company specializing in advanced silver-based antimicrobial products for wound care and skin health. The company leverages its proprietary SilverSol Technology, which utilizes a unique silver nanoparticle structure to provide broad-spectrum antimicrobial activity without the toxicity associated with traditional silver salts. Their flagship product, SilverSept, is an FDA-cleared silver antimicrobial skin and wound gel designed to inhibit the growth of microorganisms such as MRSA, VRE, and E. coli within the wound dressing. ABL Medical's solutions are used in both professional healthcare settings and for over-the-counter consumer use to manage burns, surgical incisions, and chronic ulcers. The company is headquartered in American Fork, Utah, and operates as a division of American Biotech Labs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ABL Medical.